| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |